Learn more about the use of mHealth technology
in the mental health space
A new innovation project “Personae” will provide easier access to personalised digital treatment for patients with depression through Monsenso’s digital health platform, leveraging patient-reported outcomes and AI.
Monsenso is proud to be part of the Development of an Intervention for Persistent Not On Track (DIPNOT) research project that aims to improve psychotherapeutic treatment offered to people with depression in psychiatry.
Monsenso has signed an agreement with, a global biotech company, to support the company’s medical psychedelic treatments. Awakn Life Sciences is a global biotech company that leads the field of psychedelic medicine for the treatment of addiction.
Mental health, why bother if all goes well? Because the day it hits you or your loved ones, you may be faced with the harsh reality of “Mental Health in an unequal world”. Each year, October 10th marks Worlds Mental Health Day. This year the theme is “Mental Health in an Unequal World”. Close to 1 billion people globally are living with a mental disorder. yes, countries spend on avg. 2% of their national health budgets on mental health leaving a disproportionate gap between demand and investment in mental health.
Peter Hagelund talks about his experience of getting the wrong diagnosis and how finally after six years he got the right diagnosis and treatment.
Using mHealth for suicide prevention is cost-effective and scalable. Every year, more than 800,000 people take their own lives and there are many more people who attempt suicide. Every suicide affects families and communities, leaving long-lasting effects on the people left behind. In 2012, suicide was the second leading cause of death among 15–29-year-olds globally.